Odin (ANKS1A) Modulates EGF Receptor Recycling and Stability

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Tong, Jiefei ^a   Sydorskyy, Yaroslav ^a   St Germain, Jonathan R ^a,b   Taylor, Paul ^a   Tsao, Ming S ^b,c,d   Moran, Michael F ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR PROTEIN, HUMAN; ODIN PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANKS1A GENE; ARTICLE; CELL DENSITY; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; ENDOSOME; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LYSOSOME; MOUSE; NONHUMAN; ODIN GENE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; CELL LINE; FLOW CYTOMETRY; GENETICS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; CELL LINE, TUMOR; ENDOSOMES; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84879325073     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064817     Document Type: Article

References (60)

1. Schlessinger J, (2002) Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110: 669-672.
2. Yarden Y, (2001) The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer 37Suppl 4: S3-8.
3. Sorkin A, Goh LK, (2008) Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 314: 3093-3106.
4. Grandal MV, Madshus IH, (2008) Epidermal Growth Factor Receptor and Cancer: Control of Oncogenic Signalling by Endocytosis. J Cell Mol Med 12: 1527-1534.
5. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, et al. (2006) The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim Biophys Acta 1766: 120-139.
6. Kirisits A, Pils D, Krainer M, (2007) Epidermal growth factor receptor degradation: An alternative view of oncogenic pathways. Int J Biochem Cell Biol 39: 2173-2182.
7. Thomson S, Buck E, Petti F, Griffin G, Brown E, et al. (2005) Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res 65: 9455-9462.
8. Yauch RL, Januario T, Eberhard DA, Cavet G, Zhu W, et al. (2005) Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res 11: 8686-8698.
9. Pawson T, (2004) Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116: 191-203.
10. Dengjel J, Akimov V, Olsen JV, Bunkenborg J, Mann M, et al. (2007) Quantitative proteomic assessment of very early cellular signaling events. Nat Biotechnol 25: 566-568.
11. Sharma SV, Bell DW, Settleman J, Haber DA, (2007) Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7: 169-181.
12. Schoeberl B, Pace EA, Fitzgerald JB, Harms BD, Xu L, et al. (2009) Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis. Sci Signal 2: ra31.
13. Mattoon DR, Lamothe B, Lax I, Schlessinger J, (2004) The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway. BMC Biol 2: 24.
14. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, et al. (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70: 431-442.
15. Wang Z, Moran MF, (1996) Requirement for the adapter protein GRB2 in EGF receptor endocytosis. Science 272: 1935-1939.
16. Huang F, Sorkin A, (2005) Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. Mol Biol Cell 16: 1268-1281.
17. Waterman H, Katz M, Rubin C, Shtiegman K, Lavi S, et al. (2002) A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. Embo J 21: 303-313.
18. Woodman P, (2009) ESCRT proteins, endosome organization and mitogenic receptor down-regulation. Biochem Soc Trans 37: 146-150.
19. Tong J, Taylor P, Peterman SM, Prakash A, Moran MF, (2009) Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041. Mol Cell Proteomics 8: 2131-2144.
20. Blagoev B, Ong SE, Kratchmarova I, Mann M, (2004) Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat Biotechnol 22: 1139-1145.
21. Zhang Y, Wolf-Yadlin A, Ross PL, Pappin DJ, Rush J, et al. (2005) Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol Cell Proteomics 4: 1240-1250.
22. Wolf-Yadlin A, Hautaniemi S, Lauffenburger DA, White FM, (2007) Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc Natl Acad Sci U S A 104: 5860-5865.
23. Wu SL, Kim J, Bandle RW, Liotta L, Petricoin E, et al. (2006) Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA). Mol Cell Proteomics 5: 1610-1627.
24. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, et al. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127: 635-648.
25. Imamura H, Yachie N, Saito R, Ishihama Y, Tomita M, (2010) Towards the systematic discovery of signal transduction networks using phosphorylation dynamics data. BMC Bioinformatics 11: 232.
26. Gnad F, Gunawardena J, Mann M, (2011) PHOSIDA 2011: the posttranslational modification database. Nucleic Acids Res 39: D253-260.
27. Roepstorff K, Grandal MV, Henriksen L, Knudsen SL, Lerdrup M, et al. (2009) Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic 10: 1115-1127.
28. Sorkin A, Goh LK, (2009) Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 315: 683-696.
29. Wang YN, Yamaguchi H, Hsu JM, Hung MC, (2010) Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene 29: 3997-4006.
30. Madshus IH, Stang E, (2009) Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking. J Cell Sci 122: 3433-3439.
31. Roepstorff K, Grovdal L, Grandal M, Lerdrup M, van Deurs B, (2008) Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer. Histochem Cell Biol 129: 563-578.
32. Mosesson Y, Mills GB, Yarden Y, (2008) Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 8: 835-850.
33. Singhirunnusorn P, Ueno Y, Matsuo M, Suzuki S, Saiki I, et al. (2007) Transient suppression of ligand-mediated activation of epidermal growth factor receptor by tumor necrosis factor-alpha through the TAK1-p38 signaling pathway. J Biol Chem 282: 12698-12706.
34. Winograd-Katz SE, Levitzki A, (2006) Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor. Oncogene 25: 7381-7390.
35. Zwang Y, Yarden Y, (2006) p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. Embo J 25: 4195-4206.
36. Pandey A, Blagoev B, Kratchmarova I, Fernandez M, Nielsen M, et al. (2002) Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases. Oncogene 21: 8029-8036.
37. Emaduddin M, Edelmann MJ, Kessler BM, Feller SM, (2008) Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells. Cell Commun Signal 6: 7.
38. Kristiansen TZ, Nielsen MM, Blagoev B, Pandey A, Mann M, (2004) Mouse embryonic fibroblasts derived from Odin deficient mice display a hyperproliiferative phenotype. DNA Res 11: 285-292.
39. Jones RB, Gordus A, Krall JA, MacBeath G, (2006) A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439: 168-174.
40. Sorkin A, Mazzotti M, Sorkina T, Scotto L, Beguinot L, (1996) Epidermal growth factor receptor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif. J Biol Chem 271: 13377-13384.
41. Stover D, Caldwell J, Marto J, Root K, Mestan J, et al. (2004) Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts. Clinical Proteomics 1: 69-80.
42. Zhong J, Chaerkady R, Kandasamy K, Gucek M, Cole RN, et al. (2011) The interactome of a PTB domain-containing adapter protein, Odin, revealed by SILAC. J Proteomics 74: 294-303.
43. Kajiho H, Fukushima S, Kontani K, Katada T, (2012) RINL, guanine nucleotide exchange factor Rab5-subfamily, is involved in the EphA8-degradation pathway with odin. PLoS One 7: e30575.
44. Kim J, Lee H, Kim Y, Yoo S, Park E, et al. (2010) The SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptors. Mol Cell Biol 30: 1582-1592.
45. Shin J, Gu C, Park E, Park S, (2007) Identification of phosphotyrosine binding domain-containing proteins as novel downstream targets of the EphA8 signaling function. Mol Cell Biol 27: 8113-8126.
46. Mercurio FA, Marasco D, Pirone L, Pedone EM, Pellecchia M, et al. (2012) Solution Structure of the First Sam Domain of Odin and Binding Studies with the EphA2 Receptor. Biochemistry 51: 2136-2145.
47. Tong J, Taylor P, Jovceva E, St-Germain JR, Jin LL, et al. (2008) Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. J Proteome Res 7: 1067-1077.
48. Barlow AL, Macleod A, Noppen S, Sanderson J, Guerin CJ, (2010) Colocalization analysis in fluorescence micrographs: verification of a more accurate calculation of pearson's correlation coefficient. Microsc Microanal 16: 710-724.
49. Baldys A, Gooz M, Morinelli TA, Lee MH, Raymond JR Jr, et al. (2009) Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor. Biochemistry 48: 1462-1473.
50. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, et al. (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26: 966-968.
51. Maclean B, Tomazela DM, Abbatiello SE, Zhang S, Whiteaker JR, et al. (2010) Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. Anal Chem 82: 10116-10124.
52. Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, et al. (2011) Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol 7: 548.
53. Beck M, Schmidt A, Malmstroem J, Claassen M, Ori A, et al. (2011) The quantitative proteome of a human cell line. Mol Syst Biol 7: 549.
54. Willingham MC, Haigler HT, Fitzgerald DJ, Gallo MG, Rutherford AV, et al. (1983) The morphologic pathway of binding and internalization of epidermal growth factor in cultured cells. Studies on A431, KB, and 3T3 cells, using multiple methods of labelling. Exp Cell Res 146: 163-175.
55. Longva KE, Blystad FD, Stang E, Larsen AM, Johannessen LE, et al. (2002) Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J Cell Biol 156: 843-854.
56. Kharchenko MV, Aksyonov AA, Melikova MM, Kornilova ES, (2007) Epidermal growth factor (EGF) receptor endocytosis is accompanied by reorganization of microtubule system in HeLa cells. Cell Biol Int 31: 349-359.
57. Stein BS, Bensch KG, Sussman HH, (1984) Complete inhibition of transferrin recycling by monensin in K562 cells. J Biol Chem 259: 14762-14772.
58. Sousa LP, Lax I, Shen H, Ferguson SM, De Camilli P, et al. (2012) Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane. Proc Natl Acad Sci U S A 109: 4419-4424.
59. Ullrich O, Reinsch S, Urbe S, Zerial M, Parton RG, (1996) Rab11 regulates recycling through the pericentriolar recycling endosome. J Cell Biol 135: 913-924.
60. Teis D, Huber LA, (2003) The odd couple: signal transduction and endocytosis. Cell Mol Life Sci 60: 2020-2033.